Looking for a new podcast? Listen in to Category Visionaries featuring our CEO, Dimitrios Skaltsas. You'll learn about the early days of Intelligencia AI along with actionable takeaways, finding inspiration and future vision for the company. https://lnkd.in/eiGAH_Kg
Intelligencia AI
Software Development
New York, New York 10,534 followers
Applying machine learning in drug development
About us
Intelligencia uses Artificial Intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We therefore aim to bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster. Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers brings together and interprets disparate data across the life sciences industry. Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning fueled predictions to enable critical decision making. We currently work with several of the largest global pharmaceutical companies and mid-size and smaller biotechnology companies. Diseases will impact nearly every individual. At Intelligencia AI, we work to make a difference.
- Website
-
http://www.intelligencia.ai/
External link for Intelligencia AI
- Industry
- Software Development
- Company size
- 51-200 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Artificial Intelligence, Data Science, Machine Learning, Data Visualization, Experience Design, Healthcare, Pharmaceuticals, Biotechnology, Drug Development, and Clinical Trials
Locations
-
Primary
180 Varick Street
6th Floor
New York, New York 10014, US
-
Leoforos Syngrou 80-88
2nd Floor
Athens, Attiki 11741, GR
Employees at Intelligencia AI
-
Maria Chiam. B.Pharm. MBA
Lifescience and healthcare professional
-
Aristotelis Tsirigos
Professor at NYU School of Medicine.
-
Dimitrios Skaltsas
We are hiring! Co-Founder & CEO, Intelligencia: De-risking drug development. Executive in Residence, AI at INSEAD
-
Danchen Zhao, CFA
Growth Equity | Healthtech
Updates
-
Today, we're kicking off the first installment of our Day in the Life employee blog series, where you'll get a glimpse into the intelligence behind Intelligencia AI—our people. Learn more about our scuba-diving, music-making and incredibly talented Senior Data Scientist & Bioinformatician, Agamemnon Krasoulis, and get to know him in this Q&A ➡ https://lnkd.in/eEbXTpVZ
-
-
Last month, we met at our Athens office for our much-anticipated Summer Town Hall. As a remote-first company, we deeply value the importance of building together, fostering collaboration, and caring for each other, and it's always a treat to be together. Here’s a snapshot of the dynamic time together. 🏛 𝐀𝐜𝐫𝐨𝐩𝐨𝐥𝐢𝐬 𝐓𝐨𝐮𝐫: We started with an educational and inspirational tour of the Acropolis, immersing ourselves in history and drawing inspiration from the past. 🎤 💪 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: From sharing business updates, celebrating achievements, and addressing key trends and challenges in the #pharma and #lifesciences industry, it was a time to realign and reenergize for the second half of the year. We were fortunate to host an impressive guest speaker, Lars Rasmussen, the co-founder of Google Maps and a prominent startup investor whose talk was incredibly powerful and motivating. 🍕 🏓 𝐂𝐨𝐜𝐤𝐭𝐚𝐢𝐥𝐬, 𝐏𝐢𝐳𝐳𝐚, 𝐚𝐧𝐝 𝐏𝐢𝐧𝐠 𝐏𝐨𝐧𝐠 𝐓𝐨𝐮𝐫𝐧𝐚𝐦𝐞𝐧𝐭: We ended the first day with some friendly competition, which brought out our inner child and reminded us of the joy and benefits of play. 🍷 𝐖𝐢𝐧𝐞𝐫𝐲 𝐕𝐢𝐬𝐢𝐭 𝐢𝐧 𝐍𝐞𝐦𝐞𝐚: We visited a beautiful winery in the Nemea region. We shared camaraderie while enjoying some exquisite wines and a delicious lunch in a relaxed atmosphere, strengthening our bonds as a team. ⚡ Want to learn even more about who we are as a company? Visit https://lnkd.in/eVesQ6BD
-
-
-
-
-
+4
-
-
In this blog, Angeliki Lykoudi and Dorita Metallinou recap the top takeaways and resounding themes from this year's Corvus Global Events in London last month. Read more https://lnkd.in/ecz3UNPF 💠AI Advances in Drug Discovery 💠Precision Medicine Gets More Precise 💠Drug Repositioning Will Continue to Expand 💠AI Will Drive Digital Health Forward 💠FAIR Data Is a Must-Have
-
We polled #PPM professionals in the #pharmaceutical industry, and here's what we heard about their top challenges and use of #AI. Download the results ➡ https://lnkd.in/eiZEbkRi.
-
-
Here are the five things you need to do if #AI is disrupting your industry. 💡 See AI as a window of opportunity. 💡 Know that the human element is not being erased; it's being enhanced. 💡 Make AI work for where you're at. 💡 Keep your pulse on the industry. 💡 Embrace it. Read the rest of the interview with Dimitrios Skaltsas in Authority Magazine https://lnkd.in/eZbJBBS3.
Dimitrios Skaltsas Of Intelligencia AI: How AI Is Disrupting Our Industry, and What We Can Do About…
medium.com
-
In this case study with ZS, discover how a global pharmaceutical company used data and #AI to streamline business development activities https://lnkd.in/e6JPp2F2.
Case Study: Accelerating Business Development Decisions in Oncology
intelligencia.ai
-
In our latest blog, read why we need #AI to predict the probability of success in #drugdevelopment ➡ https://lnkd.in/eNiEipCJ #pharma #lifesciences
AI is Needed to Predict the Probability of Success in Drug Development
intelligencia.ai
-
As June marks #scleroderma awareness month, we took a deep dive into our data to understand better the current and potential future state of drug development for this disease. Download the insights brief ➡ https://lnkd.in/e7en3r2g For patient and caregiver resources, visit the National Scleroderma Foundation. #EveryJourneyMatters
-
-
Industry News: Catch a recap of what's happening at the American Society of Clinical Oncology (ASCO) with the coverage from STAT https://lnkd.in/epxZMP9i. #ASCO2024
ASCO24 Archives
statnews.com